chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On December 30, 2022, I had a kidney stone. I went to the emergency room. They did a CT scan, gave me meds, and sent me home. On January 1, 2023, I was vomiting and had a 100-degree fever. I went back to the emergency room. They did another CT scan. They said I had an infection behind the stone. They put me in an ambulance and sent me to the hospital. On January 2, 2023, I had a stent put in to drain the infection. I was released from the hospital on January 3, 2023. Two weeks later, I went back to the hospital. They removed the stent. After they blasted the stone, they put the stent back. A week later, I went back to have the stent removed.
Pt recv vax on 3/24/99; on 3/25/99 pt exp fever (101.5), vomiting, diarrhea, gastroenteritis & vomiting
We didn't adminster the vaccine at our location, however, she alerted us of her reaction that started immediately after getting vaccine:  Per patient:"I had a generalized reaction. My face swelled, turned red, got hot; my throat had some swelling; I had to remove my mask to breathe. I had to stay an hour and a half before they would let me go home. My face swelling diminished over the next 24 hours."
Headache, Myalgia, chills, sore left arm, tired, Narrative:
Pt's daughter in law reports that the pt went to friend's home after the shots. She sat in chair in a stupor, after awhile states, "I don't feel well." She got up from the chair, unsteady gait-drove herself home. Noticed confusion and forgetfulness. On 10/31/2001 being treated for acute diagnosis, first contact with pt since injections. Pt did not report any reaction to injections and is still suffering from demantia.
On August 7th while donating blood I was informed my heart was skipping. On 11/10/2021 after wearing a heart monitor, having a heart Echo scan and then a stress test I was diagnosed with Ventricular premature depolarization. I have never had a heart condition before this. Along with the heart problems I have had a persistent cough, which was finally diagnosed as Asthma.  I had mild asthma in my 30's, since then I have not had any Asthma symptoms until recently.
Fri, 8/7/2020 @ 6 pm, patient had seizure activity & was transported to Medical Center by ambulance. Temp 103.4. She was released from the hospital but returned several hours later with parents. Temp 104.9. She was admitted to the hospital to monitor and treat with antibiotics. Discharged home with parents on Monday, 8/10/2020.
Lightheadness; Headache; Chills; Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Mar-2021 and was forwarded to Moderna on 19-Mar-2021.    This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Lightheadness), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (Lightheadness), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, DIZZINESS (Lightheadness), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   .
Face tingling, lips swelling, throat tightening, tongue swelling (moderate anaphylaxis reaction) and rash on neck, chest and abdomen.
Pt recvd a series of 3 Engerix-B vax on 22NOV89, 15DEC89, 30MAY90; post vax indicated that pt was a non-responder; on 09MAY91 pt recvd a booster dose for post exposure prophylaxis;
Tingling in axillary region (bilaterally) and right forearm and back and right pectoral area; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 27Mar2021 at 09:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021, the patient experienced tingling in axillary region (bilaterally) and right forearm and back and right pectoral area. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event (reported "Haven't received anything yet. Doctor's appt in hr"). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling in axillary region (bilaterally) and right forearm and back and right pectoral area was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
A legal complaint was received from an attorney who alleges that a male child received a series of haemophilus B conjugate (manuf unk), DPT (manuf unk), and hep B (manuf unk) vaccines between 8/8/94 through 9/9/99. According to the legal complaint, the "child suffers, and in future will continue to suffer from the toxic neurological effects of mercury poisoning." These injuries reportedly include "mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." The reporter claims that these injuries have resulted in a "permanent disability."
Fever - chills, diarrhea, nauseous, achy, sore throat, earache, swollen glands, severe fatigue.
Patient presented with redness and mile swelling covering half her arm on the outward aspect.  In the center of the arm where the TDaP vaccine was placed, patient also had small blisters around the injection site. Patient was directed to visit prescriber for evaluation.  Patient denied any other pain, itching, fever, or other symptoms.
Swollen Lymph nodes in left armpit area. Tender.  Felt the vaccine work its way through my arm after injection.
Pain redness swelling at injection site day1-3. Days 4&5 better.  Day7 before bed felt bumps then checked and saw redness around site slight itching. Day 9 - 2 3/4" red circle around injection site, red patch slightly irritated and hot
Soreness at injection site with 3.75 x 3.5 cm warm, pink raised area at site.
About 22 hours after the vaccination I became very weak, could not get up from the floor, was very fatigued, disoriented, and could not walk without being held up.  I  went home, and slept most of the rest of the day.  The following day I was listless with very little energy. I took several naps.  Late in the day, the second day after vaccination, I ate food and am feeling a little better.
Fever; Body ache; joint pain; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (experienced by patient when she was 25 years old). Concomitant products included Herpes zoster (Shingrix).   On 24th June 2019, the patient received the 2nd dose of Shingrix. In June 2019, less than a day after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced general body pain and joint pain. On 25th June 2019, the patient experienced fever. The patient was treated with paracetamol (Tylenol). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever, general body pain and joint pain were unknown.   It was unknown if the reporter considered the fever, general body pain and joint pain to be related to Shingrix.  Additional information was provided as follows: The patient received Shingrix and experienced body aches and joint pain. At the date of reporting, in the morning, the patient woke up with a 100 degree F fever. This case has been linked with US2019115066, reported for the dose 1 of the same patient.
administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days; it was on the refrigerator for more than 30 days then used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (it was on the refrigerator for more than 30 days then used) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 27-May-2022, the patient experienced PRODUCT STORAGE ERROR (it was on the refrigerator for more than 30 days then used). On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (it was on the refrigerator for more than 30 days then used) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Number of doses was 1 vial 1 dose. The vial was initially stored in the refrigerator was on 27-May-2022. The vial did not undergo any temperature excursions.  No treatment drug detail was reported.
Severe headache, body aches, chills, fever, nausea, severe weakness including fainting episodes x 18 hours. Weakness, nausea ongoing still.
This spontaneous case, initially received from the other health professional (nurse) on 07-Nov-2018, concerns a 47-year-old adult female patient. On an unspecified date, the vaccines were stored in the refrigerator and eventually a temperature drop was noted for a moment up to plus 0.3 Celsius for less than 115 minutes, which was considered as first temperature excursion. It was reported that the vaccines were moved immediately. On 26-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252227 and expiry date: 31-May-2019] which underwent temperature excursion. The patient did not experience any adverse reactions after vaccination. The reporter assessed this case as non-serious. This case (201805333) was cross-linked to case 201805327 due to same reporter. Follow-up report received from other health profession on 28-Nov-2018: The patient's age (47-year-old adult) was added. The route of administration (intramuscular) and anatomical location (left deltoid) of suspect vaccine were added in the product tab. The reporter confirmed that, the patient did not experience any adverse reactions. The narrative and case comment were amended accordingly.
pt devel 20 vesicles that crusted chest, abd, thighs, 1 on tongue;runny nose before eruption;no cough;no fever;no known exposure;
A physician reported that an unidentified person may have inadvertently received an expired dose of DTP. The physician declined to proved any further information. Follow up information has been received from the reporter on 2/6/01. The physician explained that an unidentified attorney called to inquire if there are any known adverse effects of receiving an expired DTP vaccine. The physician states "I do not know who the pt is, nor what company produced the vaccine". It is unknown if the pt experienced any adverse event from this vaccine.
While giving the vaccine to the patient, the medication leaked out from the connection point between needle and syringe. I believe that over half of the dose was wasted. I gave a replacement vaccine in the other arm.
Temperature of 102.2F (R), pale and crying. Went to ER for full work-up, 6 hours, post vax.
Patient stated she could not breathe good, migraines worsened, and heart was racing. She stated she took a bath, washed with antiseptic soap, and dressed in silky clothing and this helped. Her son later gave her BENADRYL.
myasthenia gravis symptoms; booster; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Aug2021 12:00 (Batch/Lot number: unknown) at the age of 60 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "crps" (unspecified if ongoing); "Scoliosis" (unspecified if ongoing); "Epilepsy" (unspecified if ongoing); "Hashimotos" (unspecified if ongoing); "known allergies: Some medication" (unspecified if ongoing). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included: SYNTHROID; FEMRING; PANTOPRAZOLE and medical canna. Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left), for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Location of injection: Arm Left), for Covid-19 immunization. The following information was reported: IMMUNISATION (hospitalization, disability, medically significant) with onset 21Aug2021 12:00, outcome "unknown", described as "booster"; MYASTHENIC SYNDROME (hospitalization, disability, medically significant) with onset 25Aug2021, outcome "not recovered", described as "myasthenia gravis symptoms". The patient was hospitalized for immunisation, myasthenic syndrome (hospitalization duration: 3 day(s)). The event "myasthenia gravis symptoms" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of myasthenic syndrome. Treatment includes pyridostigmine, breathing, tests etc. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Numbness and loss of sensation in left side where shot was injected. Headache on left side. Uncontrollable eye twitching, fast heart beat, pain in chest, pressure in head. Throat closing and itchiness on left side of body.
light headnes  and down to floor but was concious and speakable and mother and patient refused to call 911 eventhough pharmacist on duty offered.
Evening of injection a few hives appeared on on left breast area, hives continued to increase the following day. Chills, muscle weakness and flu-like aching began the day after injection and is still continuing today.
vasovagal reaction unresponsive diaphoretic after vaccine  Awake upon MD eval.   bp 106/65, HR 55 Received juice, observation
Itchiness and some small red bumps around the area of injection. Treated with BENADRYL 25 mg as needed for 2-3 days.
This is a prospective pregnancy case. This female subject was enrolled in an open label study. The subject received BOOSTRIX on 21st June 2016. The subject received BOOSTRIX at week 32 of the pregnancy and during the third trimester of pregnancy. In June 2016, an unknown time after receiving BOOSTRIX, the subject developed fetal movements decreased. Serious criteria included GSK medically significant. Additional event(s) included vaccine exposure during pregnancy. The outcome of fetal movements decreased was unknown. The outcome(s) of the additional event(s) included vaccine exposure during pregnancy (unknown). The pregnancy was ongoing. It was unknown if the investigator considered the fetal movements decreased and vaccine exposure during pregnancy to be related to BOOSTRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient's date of birth was refused. The patient was at 32 weeks of gestation and had an exposure to BOOSTRIX. The patient also experienced decreased fetal movement. The reporter was unable to quantify the decreased fetal movement. The reported lot number (7RJ98) for BOOSTRIX did not exist and was updated to 7RJ9B, according to sales database.
Itching,swelling,redness and increased heat at injection site starting at day 9  following injection.
Patient says that approximately 2 1/2 weeks since she received both vaccines and her arm is still very sore. I examined the arm and there is no redness or discoloration at the vaccine sites. It was the patient's Left arm.
Myalgia, Fever, Fever, HA, Fatigue started 24 hrs post vaccine and lasted < 24 hrs.  Narrative:  Fever, HA, Fatigue started 24 hrs post vaccine and lasted < 24 hrs. She states she would have missed work if it had been a work day.
Pt presented to local ED with fever to 104 with headache and myalgias (10 day out from Smallpox vaccination).  W/u exam all normal, pt followed up in 24 hours with significant resolution of symptoms.
S/S soreness & tenderness in R arm, redness at injection site with red streak going around inner 1/2 of arm. Achiness, fever no degrees. Induration at injection site. TX: Benadryl Injection & Ice to injection site.
Left thigh cellulitis at site of PEDIARIX immunization. Rx: BACTRIM x 7 days.
Pt. states that after receiving the 3rd dose of Phizer 12/27/2021, started experiencing symptoms that evening of round swelling at the injection site, moved to the Left under arm area, chills, and nausea. No noted Primary visit/communications. Still experiencing symptoms .
Bacterial cellulitis spreading down his leg around the injection site.   He was given an antibiotic and prednisone by the same facility.  It appears to be healing.
ED with SOB/cough x3-4 days; +covid PNA; VSS; Labs:  D-dimer 0.56;     TX: steroids, antibiotics (doxycycline, maxipime), Vit C, Vit D3, Vit b12, Zinc, Tessalon Perles, supplemental O2 (2L NC); back to room air baseline by d/c
The next morning following the vaccine injection, (4/1/21) I woke up to pain in my lymphnodes in my right armpit. I recieved the injection in my right arm. It was a dull achey pain but upon palpation became a sharp shooting pain that radiated from my armpit into my back and under my ribcage. There was also swelling and it to hurt have my right arm resting along my side.  Today, on 4/2/21, I am still experiencing this pain, however, it is less severe. To treat, I have been taking 2 acetominaphen approximately every six hours. It still hurts if I am to rest my arm at my side.
The day after the injection, the injection site became swollen and painful and the right shoulder ached. This fully resolved the next day.  10 days later, the right shoulder suddenly became swollen and painful and I could not raise my arm above my shoulder. It was difficult to sleep because of the pain. Within 2 weeks, the pain subsided but I was still unable to raise my right arm. A picture of my back showed the right shoulder blade appeared detached from the back (picture available upon request.)  I visited the doctor on April 2 who ordered Xray? CT? of the shoulder but could find nothing specific to explain the incident.  covid vaccine? unrelated?  The movement of my right shoulder is improving slowly.
Headache, beginning on 4-21 Sleeplessness, beginning on 4-21 Abdominal pain and generalized weakness, beginning on 4-21 Higher than normal blood pressure  189/91 in ER   Went to the ER  on  Wed. 4-21, and Friday, 4-23.   Went to see PCP,  on Monday, 4-26. Chills-- No fever  on 4-28-2021. Shortness of breath Pressure on upper back, with weakness of both legs
Rash; This is a spontaneous case, reported by pharmacist to Med Communications (case ID: SEQ19-06954) and initially received on 22-Nov-2019, concernig a female patient of unknown age.  The patients relevant medical history was not provided.  The patients concomitant medications were not provided.  On an unspecified date, the patient was administered Flucelvax QIV [Influenza vaccine, subunit influenza virus vaccine polyvalent, dose, route of administration, anatomical location, batch number and expiration date: not reported] for an unknown indication.  On an unspecified date, after vaccination the patient did have a rash. The patient wondered if it was because the vaccine might contain antibiotics.  The outcome of the event rash was not provided, at the time of this report.  The reporter did not provide causality and seriousness criteria.  Company Comment: Event's causality was assessed as related to the suspect product per company.; Sender's Comments: Event's causality was assessed as related to the suspect product per company.
leg formed a blood clot above knee; Severe pain; Numbing in arm and leg; This is a spontaneous report from a contactable other healthcare professional (patient). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 23Mar2021 10:00 (Batch/Lot Number: unknown) as 1ST DOSE, SINGLE for Covid-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included complications from bladder mesh and mitral valve prolapse. The patient's concomitant medications included Vitamins (unspecified). The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 06:00, the patient experienced severe pain followed by numbing in arm and leg, and leg formed a blood clot above knee. The patient tried to make doctor appointment but 40 days out. The patient took aspirin daily for clot and will see doctor in 2 weeks. No treatment was received for severe pain and numbing in arm and leg. The patient has not been tested for COVID-19 since the vaccination. The outcome of events severe pain and numbing in arm and leg was recovering; outcome of event leg formed a blood clot above knee was recovered on an unspecified date.  Information on the lot/batch number has been requested.
Headache, stomach ache, rash 2in diameter. Rash got blisters and bleed.
Tingling, pain, burning, prodromal-like on left cheek from cheekbone to ear to eye and left nostril. Started morning of 3/24 and stopped afternoon of 3/2/18. Ice was only mildly effective in that it numbed but did not stop the sensation.
Started as chapped lips.  Developed into a viral AND bacterial infections.  Impetico with sores in and around the mouth and nose.  Dr says the virus was brought out due to vaccine since it is for viral infection.  And later because infected with bacteria